Halyna Tomashkevych Галина Томашкевич|Galina Tomashkevich

Halyna Tomashkevych Галина Томашкевич|Galina Tomashkevich

National Pirogov Memorial Medical University, Vinnytsya - / Ukraine
Medical and Health Sciences / Chest Diseases
AD Scientific Index ID: 5291810
Натіонал Пирогов Меморіал Медікал Універсіті, Вінниця
person_outline Halyna Tomashkevych Галина Томашкевич|Galina Tomashkevich's MOST POPULAR ARTICLES
1-) Canagliflozin and renal outcomes in type 2 diabetes and nephropathy V Perkovic, MJ Jardine, B Neal, S Bompoint, HJL Heerspink, ... New England journal of medicine 380 (24), 2295-2306, 2019 50602019
2-) Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: the CARMELINA randomized clinical trial J Rosenstock, V Perkovic, OE Johansen, ME Cooper, SE Kahn, N Marx, ... Jama 321 (1), 69-79, 2019 10872019
3-) Triglyceride lowering with pemafibrate to reduce cardiovascular risk A Das Pradhan, RJ Glynn, JC Fruchart, JG MacFadyen, ES Zaharris, ... New England Journal of Medicine 387 (21), 1923-1934, 2022 3372022
4-) The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) study rationale, design, and baseline characteristicsMJ Jardine, KW Mahaffey, B Neal, R Agarwal, GL Bakris, BM Brenner, ...American journal of nephrology 46 (6), 462-472, 20182562018
5-) Linagliptin effects on heart failure and related outcomes in individuals with type 2 diabetes mellitus at high cardiovascular and renal risk in CARMELINADK McGuire, JH Alexander, OE Johansen, V Perkovic, J Rosenstock, ...Circulation 139 (3), 351-361, 20191722019